| Company Name | Shijiazhuang Yiling Pharmaceutical Co., Ltd. | ||
| English full name | SHIJIAZHUANG YILING PHARMACEUTICALCO., LTD | ||
| English full name | Yiling Pharmaceutical | Securities code: | 002603 |
| Place of listing | Shenzhen Stock Exchange | Listing date: | 2011-07-28 |
| Information Disclosure Newspaper Name: | "China Securities News", "Shanghai Securities News", "Securities Times", "Securities Daily" | ||
| Place where the statutory report is prepared: | Office of the Board of Directors of Shijiazhuang Yiling Pharmaceutical Co., Ltd. | ||
| The website designated by the China Securities Regulatory Commission for publishing the annual report : |
http://www.cninfo.com.cn | ||
| legal representative: | Wu Xiangjun | Chairman: | Wu Yiling |
| General manager | Wu Xiangjun | ||
| Secretary of the Board: | Wu Rui | Securities Affairs Representative: | Wang Hua |
| Main business | R&D, production and sales of drugs | ||
| office address | No. 238 Tianshan Street, High-tech Industrial Development Zone, Shijiazhuang City, Hebei Province | ||
| Office Zip Code: | 050035 | fax: | 0311-85901311 |
| contact number: | 0311-85901311 | Secretary of the Board's mailbox: | wurui@yiling.cn |
| company website: | www.yilingbiotech.com | ||
